Listed by the USPTO as KUCHARCZK, JED A
Tech Center 1600 • Art Units: 1623 1626
This examiner grants 80% of resolved cases
KUCHARCZK, JED A is assigned to tech center 1600 and art unit 1623. The profile records 97 resolved cases and an allowance rate of 80.4%. Interview lift is 16.3%, indicating that interviews have a measurable but limited role in the available record. The median time to allowance is 1021 days, supporting advance planning for responses and continuation decisions.
The listed companies are Hoffmann-La Roche Inc., Novartis AG, and Nestlé S.A. The firms shown are COOLEY LLP, FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, and FITCH, EVEN, TABIN & FLANNERY, LLP. Practitioners may use interviews to clarify technical distinctions while maintaining a strong written prosecution record.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19010516 | PHOSPHORYLPURINONE COMPOUNDS FOR THE TREATMENT OF CANCER | Non-Final OA | Hoffmann-La Roche Inc. |
| 18939314 | PYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF | Non-Final OA | Novartis AG |
| 17721813 | COMPOSITIONS AND THEIR USE | Final Rejection | SOCIÉTÉ DES PRODUITS NESTLÉ S.A. |
| 19220457 | METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONS | Final Rejection | Otsuka Pharmaceutical Co., Ltd. |
| 18547800 | MELANOCORTIN-4 RECEPTOR AGONIST | Non-Final OA | LG CHEM, LTD. |
| 17628106 | Modulators of Excitatory Amino Acid Transporters and Methods Using Same | Non-Final OA | Drexel University |
| 17258112 | COMPOSITION CONTAINING A 7BETA-HYDROXYCHOLESTEROL AND A LIPID VEHICLE, AND ITS USE IN THE TREATMENT OF NEOPLASTIC PATHOLOGIES | Non-Final OA | BETA INNOV |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy80.4% of resolved applications examined by Jed A Kucharczk were allowed (97 resolved cases), compared with 51.3% across Art Unit 1623 over the last five years.
This examiner's interview lift is +16.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jed A Kucharczk took 1,021 days on average from filing to allowance.
Jed A Kucharczk examines applications in Art Unit 1623 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
